Sars-cov-2, sociaenza a & b antigen hui i hui pūʻiaʻo Kit-EU Ce

ʻO Covid-19, Flu a a iʻole ka maʻi BF i keʻano like me ka hoʻomaʻamaʻaʻana i ka maʻi o ka maikaʻi

KA MEA

ʻO keʻano kūpono e pili ana i keʻano o ka diagnosis

ʻOiai e kaʻana like i ka hōʻailona like, Covid-19, FLUE A a me Flu BFFICE e pono ai ka hoʻomaʻamaʻaʻokoʻa. Hiki ke mālamaʻiaʻo Originza me nā mea hoʻokūkū Neuraminidase a me nā mea koʻikoʻi i ka covid-19 me ka retrovivir / sotrovimab.

ʻO ka hopena maikaʻi i hoʻokahi virusʻaʻole ia he meaʻoleʻoe e hoʻokuʻu i nā poʻe'ē aʻe. ʻO nā pilikia co-thefections e hoʻonui ai i nā maʻi nui, ka haukapila, ka make ma muli o nā hopena synergistic.

ʻO ka maʻi kūpono e kūpono ai ma ka hōʻikeʻana he nui e alakaʻi i keʻano o ka hana antivIral kūponoʻole

ʻO kā mākou mau hoʻoponopono

Macro & Micro-hōʻikeSars-Cov-2, Rountienza A & B antigen hui pūʻia,ʻokoʻa i ka flu a, flu b a me covid-19 me ka lehulehu o ka maʻi hanu

ʻO ka ho'āʻoʻana o ka wikiwiki o nā maʻi he nui, e komo pū me nā sars-cov-2, flu a,

Hoʻohui piha hōʻike hōʻike hōʻike me kahi'āpana helu hoʻokahi a me nā hiʻohiʻona hoʻokahi e pono ai i kaʻokoʻa ma waena o nā kālā-19, flu a me ka a me ka flu b;

ʻO 4 mau hana wale nō no ka rapid Nā hopena i ka 15-20 MIN wale nō, e hiki ai ke hoʻomaikaʻi wikiwiki i ka hoʻoholoʻana.

Nāʻano hua'ōlelo he nui

Mahele ala: 4 -30 ° C;

Iho Ola: 24 mau mahina.

ʻO nā hiʻohiʻona lehulehu e like me nā haukapila, nā lāʻau lapaʻau, nā lāʻau lapaʻau olakino, nā lāʻau lapaʻau, nā lāʻau lapaʻau, etc.

Sars-cov-2

'Ōpū A

'ŌpūNa B

Luhi

94.36%

94.92%

93.79%

Kiko'ī

99.81%

99.81%

100.00%

Pololei

98.31%

98.59%

98.73%


Post manawa: Jan-18-2024